Literature DB >> 18983492

Plasmin enhances cell surface tissue factor activity in mesothelial and endothelial cells.

H Kothari1, G Kaur, S Sahoo, S Idell, L V M Rao, U Pendurthi.   

Abstract

BACKGROUND: Mesothelial cells that line the thoracic cavity play an important role in maintaining the local balance between procoagulant and fibrinolytic activity, a role akin to the endothelial cells in blood vessels. The mechanism(s) responsible for increased tissue factor (TF) expression in mesothelial cells in response to injury are at present unclear.
OBJECTIVE: To investigate whether plasmin or thrombin, two major proteases that may be generated on the pleural surface upon injury, induce TF expression in human pleural mesothelial cells (HMC) and elucidate the underlying mechanism(s).
METHODS: Confluent monolayers of HMC and human umbilical vein endothelial cells (HUVEC) were exposed to plasmin or thrombin for varying time periods and TF expression was analyzed by measuring its activity in a factor Xa generation assay, TF antigen levels by immunoblot analysis and TF mRNA by Northern blot analysis.
RESULTS: Both plasmin and thrombin treatments increased cell surface TF activity in HMC by 3- to 4-fold. In contrast to thrombin, plasmin-induced TF activity is not dependent on the de novo synthesis of TF. In HUVEC, plasmin had a minimal effect on unperturbed HUVEC whereas it markedly increased TF activity of activated HUVEC. Plasmin treatment neither affected anionic phospholipid levels at the cell surface nor released protein disulfide isomerase, an oxidoreductase protein that was newly described to play a role in TF activation. Plasmin cleaved cell-associated TFPI.
CONCLUSION: Thrombin up-regulates TF activity in HMC through the transcriptional activation of TF whereas plasmin increases TF activity by inactivating the cell-associated TFPI by a limited proteolysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983492      PMCID: PMC2605520          DOI: 10.1111/j.1538-7836.2008.03218.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  54 in total

1.  Infarct artery reocclusion after primary angioplasty, stent placement, and thrombolytic therapy for acute myocardial infarction.

Authors:  S H Wilson; M R Bell; C S Rihal; K R Bailey; D R Holmes; P B Berger
Journal:  Am Heart J       Date:  2001-05       Impact factor: 4.749

2.  Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction.

Authors:  Ilka Ott; Valerie Malcouvier; Albert Schömig; Franz-Josef Neumann
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

Review 3.  Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

Authors:  M S Pepper
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-07       Impact factor: 8.311

Review 4.  Plasmin and matrix metalloproteinases in vascular remodeling.

Authors:  H R Lijnen
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

Review 5.  Annexin II: a plasminogen-plasminogen activator co-receptor.

Authors:  Jiyun Kim; Katherine A Hajjar
Journal:  Front Biosci       Date:  2002-02-01

6.  Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells.

Authors:  M S Bajaj; U Pendurthi; K Koenig; S Pueblitz; S Idell
Journal:  Eur Respir J       Date:  2000-06       Impact factor: 16.671

7.  Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor.

Authors:  P G Stalboerger; C J Panetta; R D Simari; N M Caplice
Journal:  Thromb Haemost       Date:  2001-09       Impact factor: 5.249

8.  Tissue factor activation: is disulfide bond switching a regulatory mechanism?

Authors:  Usha R Pendurthi; Samit Ghosh; Samir K Mandal; L Vijaya Mohan Rao
Journal:  Blood       Date:  2007-08-28       Impact factor: 22.113

9.  Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.

Authors:  Haiwang Tang; Lacramioara Ivanciu; Narcis Popescu; Glenn Peer; Erik Hack; Cristina Lupu; Fletcher B Taylor; Florea Lupu
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

Review 10.  Coagulation and inflammation in acute lung injury.

Authors:  Karen E Welty-Wolf; Martha S Carraway; Thomas L Ortel; Claude A Piantadosi
Journal:  Thromb Haemost       Date:  2002-07       Impact factor: 5.249

View more
  12 in total

Review 1.  Tissue factor encryption and decryption: facts and controversies.

Authors:  L Vijaya Mohan Rao; Hema Kothari; Usha R Pendurthi
Journal:  Thromb Res       Date:  2012-03-06       Impact factor: 3.944

2.  Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.

Authors:  Sandip M Kanse; Paul J Declerck; Wolfram Ruf; George Broze; Michael Etscheid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

Review 3.  Novel therapeutic targets for preserving a healthy endothelium: strategies for reducing the risk of vascular and cardiovascular disease.

Authors:  Joseph Ramli; Pedro CalderonArtero; Robert C Block; Shaker A Mousa
Journal:  Cardiol J       Date:  2011       Impact factor: 2.737

4.  Plasmin-dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia.

Authors:  C Lupu; O Herlea; H Tang; R H Lijnen; F Lupu
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

5.  Thrombin down-regulates tissue factor pathway inhibitor expression in a PI3K/nuclear factor-κB-dependent manner in human pleural mesothelial cells.

Authors:  Ann Jeffers; Shuzi Owens; Kathleen Koenig; Brandon Quaid; Usha R Pendurthi; Vijaya M Rao; Steven Idell; Torry A Tucker
Journal:  Am J Respir Cell Mol Biol       Date:  2015-06       Impact factor: 6.914

6.  Microstructure and Mechanical Property of Glutaraldehyde-Treated Porcine Pulmonary Ligament.

Authors:  Huan Chen; Xuefeng Zhao; Zachary C Berwick; Joshua F Krieger; Sean Chambers; Ghassan S Kassab
Journal:  J Biomech Eng       Date:  2016-06       Impact factor: 2.097

7.  Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential.

Authors:  Steven Idell; Galina Florova; Sreerama Shetty; Torry Tucker; Richard Idell; Kathy Koenig; Ali Azghani; Najib M Rahman; Andrey Komissarov
Journal:  Clin Pulm Med       Date:  2017-07

Review 8.  Tissue factor pathway inhibitor: structure-function.

Authors:  George J Broze; Thomas J Girard
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

Review 9.  Tissue factor: mechanisms of decryption.

Authors:  L Vijaya Mohan Rao; Hema Kothari; Usha R Pendurthi
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

10.  Folliculin haploinsufficiency causes cellular dysfunction of pleural mesothelial cells.

Authors:  Shouichi Okamoto; Hiroki Ebana; Masatoshi Kurihara; Keiko Mitani; Etsuko Kobayashi; Takuo Hayashi; Yasuhito Sekimoto; Koichi Nishino; Mizuto Otsuji; Toshio Kumasaka; Kazuhisa Takahashi; Kuniaki Seyama
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.